Free Trial

Pharvaris (PHVS) News Today

Pharvaris logo
$14.82 -0.27 (-1.79%)
Closing price 04/23/2025 04:00 PM Eastern
Extended Trading
$14.90 +0.08 (+0.57%)
As of 04/23/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Pharvaris stock logo
Rock Springs Capital Management LP Purchases 18,200 Shares of Pharvaris (NASDAQ:PHVS)
Rock Springs Capital Management LP raised its position in shares of Pharvaris (NASDAQ:PHVS - Free Report) by 2.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 775,131 shares of the company's stock af
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Stock Price Up 7.8% - Still a Buy?
Pharvaris (NASDAQ:PHVS) Trading Up 7.8% - Time to Buy?
Pharvaris stock logo
Fmr LLC Has $103.43 Million Holdings in Pharvaris (NASDAQ:PHVS)
Fmr LLC increased its position in Pharvaris (NASDAQ:PHVS - Free Report) by 3.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 5,395,370 shares of the company's stock after purchasing an additional 189,714 shares during the period. Fmr LLC owned about 10
Pharvaris stock logo
Q1 Earnings Estimate for Pharvaris Issued By Leerink Partnrs
Pharvaris (NASDAQ:PHVS - Free Report) - Analysts at Leerink Partnrs dropped their Q1 2025 EPS estimates for Pharvaris in a report released on Monday, April 7th. Leerink Partnrs analyst J. Schwartz now forecasts that the company will post earnings of ($0.91) per share for the quarter, down from th
Pharvaris stock logo
Wedbush Comments on Pharvaris' Q1 Earnings (NASDAQ:PHVS)
Pharvaris (NASDAQ:PHVS - Free Report) - Analysts at Wedbush lowered their Q1 2025 EPS estimates for shares of Pharvaris in a research report issued to clients and investors on Monday, April 7th. Wedbush analyst L. Chico now forecasts that the company will post earnings of ($0.92) per share for th
Pharvaris stock logo
What is Wedbush's Estimate for Pharvaris FY2029 Earnings?
Pharvaris (NASDAQ:PHVS - Free Report) - Equities researchers at Wedbush issued their FY2029 EPS estimates for Pharvaris in a research note issued on Monday, April 7th. Wedbush analyst L. Chico forecasts that the company will post earnings of $5.99 per share for the year. The consensus estimate fo
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Hits New 12-Month Low - Here's What Happened
Pharvaris (NASDAQ:PHVS) Sets New 12-Month Low - Should You Sell?
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Stock Price Down 8.4% - Here's What Happened
Pharvaris (NASDAQ:PHVS) Stock Price Down 8.4% - Here's What Happened
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPS
Pharvaris (NASDAQ:PHVS - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.68) EPS for the quarter, beating analysts' consensus estimates of ($0.74) by $0.06.
Pharvaris reports Q4 EPS (EUR 0.64) vs. (EUR 0.95) last year
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Sets New 12-Month Low - Time to Sell?
Pharvaris (NASDAQ:PHVS) Reaches New 12-Month Low - What's Next?
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - What's Next?
Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - Here's What Happened
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Stock Price Down 4.3% - What's Next?
Pharvaris (NASDAQ:PHVS) Trading Down 4.3% - What's Next?
Pharvaris stock logo
Pharvaris (PHVS) Projected to Post Earnings on Wednesday
Pharvaris (NASDAQ:PHVS) will be releasing earnings before the market opens on Wednesday, April 9, Financial Modeling Prep reports.
Pharvaris says EC grants orphan designation to deucrictibant
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Trading Up 6% - Still a Buy?
Pharvaris (NASDAQ:PHVS) Trading 6% Higher - Here's What Happened
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Trading Up 5.5% - Should You Buy?
Pharvaris (NASDAQ:PHVS) Shares Up 5.5% - Still a Buy?
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Stock Price Down 3.2% - Time to Sell?
Pharvaris (NASDAQ:PHVS) Trading Down 3.2% - Should You Sell?
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Short Interest Up 24.7% in February
Pharvaris (NASDAQ:PHVS - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 28th, there was short interest totalling 487,300 shares, a growth of 24.7% from the February 13th total of 390,900 shares. Based on an average trading volume of 55,500 shares, the days-to-cover ratio is currently 8.8 days. Approximately 2.8% of the company's stock are short sold.
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Shares Gap Down - Should You Sell?
Pharvaris (NASDAQ:PHVS) Shares Gap Down - Here's What Happened
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Trading 4.3% Higher - Still a Buy?
Pharvaris (NASDAQ:PHVS) Trading 4.3% Higher - Here's What Happened
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Shares Gap Down - What's Next?
Pharvaris (NASDAQ:PHVS) Shares Gap Down - Here's What Happened
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Shares Gap Up - Time to Buy?
Pharvaris (NASDAQ:PHVS) Shares Gap Up - Should You Buy?
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Short Interest Update
Pharvaris (NASDAQ:PHVS - Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 390,900 shares, a growth of 25.7% from the January 31st total of 311,100 shares. Approximately 2.3% of the company's shares are short sold. Based on an average daily volume of 64,900 shares, the short-interest ratio is currently 6.0 days.
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Trading Down 5.7% - Here's Why
Pharvaris (NASDAQ:PHVS) Shares Down 5.7% - Should You Sell?
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Sets New 1-Year Low - Time to Sell?
Pharvaris (NASDAQ:PHVS) Sets New 52-Week Low - Here's Why
Pharvaris reports safety and efficacy data of deucrictibant
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Hits New 12-Month Low - Should You Sell?
Pharvaris (NASDAQ:PHVS) Sets New 1-Year Low - Time to Sell?
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Still a Buy?
Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - Should You Buy?
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Sees Strong Trading Volume - What's Next?
Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - What's Next?
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - Time to Buy?
Pharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Here's Why
Pharvaris price target raised to $55 from $46 at JMP Securities
Pharvaris stock logo
JMP Securities Issues Positive Forecast for Pharvaris (NASDAQ:PHVS) Stock Price
JMP Securities lifted their price target on Pharvaris from $46.00 to $55.00 and gave the stock a "market outperform" rating in a research note on Friday.
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Shares Gap Down - Here's What Happened
Pharvaris (NASDAQ:PHVS) Shares Gap Down - What's Next?
Pharvaris stock logo
Pharvaris FY2026 EPS Estimate Reduced by Leerink Partnrs
Pharvaris (NASDAQ:PHVS - Free Report) - Investment analysts at Leerink Partnrs dropped their FY2026 earnings per share estimates for Pharvaris in a report released on Monday, January 20th. Leerink Partnrs analyst J. Schwartz now expects that the company will post earnings of ($2.87) per share for
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Shares Up 5.3% - Here's Why
Pharvaris (NASDAQ:PHVS) Stock Price Up 5.3% - Here's Why
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Shares Down 11.7% - Here's What Happened
Pharvaris (NASDAQ:PHVS) Shares Down 11.7% - What's Next?
Pharvaris N.V.: Pharvaris Outlines 2025 Strategic Priorities
Pharvaris Outlines 2025 Strategic Priorities
Pharvaris stock logo
Jane Street Group LLC Makes New Investment in Pharvaris (NASDAQ:PHVS)
Jane Street Group LLC purchased a new position in Pharvaris (NASDAQ:PHVS - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 28,418 shares of the company's stock, valued at approximately $526,000. Jane St
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Here's What Happened
Pharvaris (NASDAQ:PHVS) Sees Strong Trading Volume - Time to Buy?
Get Pharvaris News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHVS and its competitors with MarketBeat's FREE daily newsletter.

PHVS Media Mentions By Week

PHVS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PHVS
News Sentiment

0.95

0.74

Average
Medical
News Sentiment

PHVS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PHVS Articles
This Week

2

2

PHVS Articles
Average Week

Get Pharvaris News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHVS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:PHVS) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners